HO, O., ME, M., AR, B., C, M. d. l. C., & RE, M. (2021). Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. Nature communications, 12(1), 4934. https://doi.org/10.1038/s41467-021-25204-3
Chicago Style (17th ed.) CitationHO, Orlans, McClements ME, Barnard AR, Martinez-Fernandez de la Camara C, and MacLaren RE. "Mirtron-mediated RNA Knockdown/replacement Therapy for the Treatment of Dominant Retinitis Pigmentosa." Nature Communications 12, no. 1 (2021): 4934. https://doi.org/10.1038/s41467-021-25204-3.
MLA (9th ed.) CitationHO, Orlans, et al. "Mirtron-mediated RNA Knockdown/replacement Therapy for the Treatment of Dominant Retinitis Pigmentosa." Nature Communications, vol. 12, no. 1, 2021, p. 4934, https://doi.org/10.1038/s41467-021-25204-3.